Kirkland Advises Linden Capital Partners on Formation of $1.5 Billion Healthcare Fund

Kirkland & Ellis LLP counseled Linden Capital Partners on the formation of Linden Capital Partners IV, which announced its final closing with $1.5 billion of limited partner capital commitments.  Since its inaugural fund in 2005, Linden has pursued an investment strategy in private equity focused on adding significant value to middle market healthcare companies in the services, medical products, specialty distribution, and pharmaceutical sectors, among others.  The Fund was oversubscribed, exceeding its target of $1.25 billion and hitting its hard cap.  The Fund’s limited partners include endowments, financial institutions and pension funds. Read the full release here.  

The Kirkland team was led by investment funds partners Nicholas DiCrescenzo and Bruce Ettelson and associates Daniel McQuade, Noah Mullin and Alyssa Jutovsky; and included investment management partner Corey Zarse; tax partners Daniel Meehan and Aalok Virmani and associate Nicholas Warther; and employee benefits partner Elizabeth Dyer.

Kirkland is a global leader in providing sophisticated advice to investment fund sponsors, institutional investors and other market participants in the alternative investment fund space. Kirkland offers clients the unsurpassed resources of a large, integrated, multidisciplinary, global team located across offices in the United States, Europe and Asia-Pacific. With more than 260 dedicated Investment Funds attorneys, including over 100 partners, few firms approach the breadth, depth and scope of Kirkland’s experience in investment funds legal services. In the past three years alone, Kirkland has advised nearly 300 private investment fund sponsors, raising more than 400 funds representing in excess of $440 billion of capital commitments.